Literature DB >> 16720960

Treatment of cognitive impairment in multiple sclerosis.

Susan H Pierson1, Nathan Griffith.   

Abstract

Cognitive impairment in multiple sclerosis is an increasingly recognized entity. This article reviews the cognitive impairment of multiple sclerosis, its prevalence, its relationship to different types of multiple sclerosis, and its contribution to long-term functional prognosis. The discussion also focuses on the key elements of cognitive dysfunction in multiple sclerosis which distinguish it from other forms of cognitive impairment. Therapeutic interventions potentially effective for the cognitive impairment of multiple sclerosis are reviewed including the effects of disease modifying therapies and the use of physical and cognitive interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720960      PMCID: PMC5471535          DOI: 10.1155/2006/545860

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  12 in total

1.  A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Heather Becker; Frank Perez; Janet Morison; Vicki Kullberg; Ana Todd
Journal:  Clin Rehabil       Date:  2012-02-02       Impact factor: 3.477

2.  Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.

Authors:  Heather Becker; Alexa Stuifbergen; Hwayoung Lee; Vicki Kullberg
Journal:  Int J MS Care       Date:  2014

3.  Escalating immunotherapy of multiple sclerosis.

Authors:  Peter Rieckmann; Anthony Traboulsee; Virginia Devonshire; Joel Oger
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

4.  Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Authors:  Francesco Patti; Maria Pia Amato; Stefano Bastianello; Luisa Caniatti; Elisabetta Di Monte; Fausto Lijoi; Benedetta Goretti; Silvia Messina; Orietta Picconi; Maria Rosalia Tola; Maria Trojano
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

5.  Factors affecting employment among informal caregivers assisting people with multiple sclerosis.

Authors:  Robert J Buchanan; Chunfeng Huang; Zhida Zheng
Journal:  Int J MS Care       Date:  2013

6.  Home-Based Computer-Assisted Cognitive Training: Feasibility and Perceptions of People with Multiple Sclerosis.

Authors:  Alexa Stuifbergen; Heather Becker; Stephanie Morgan; Janet Morrison; Frank Perez
Journal:  Int J MS Care       Date:  2011-01-01

7.  Variables associated with communicative participation in people with multiple sclerosis: a regression analysis.

Authors:  Carolyn Baylor; Kathryn Yorkston; Alyssa Bamer; Deanna Britton; Dagmar Amtmann
Journal:  Am J Speech Lang Pathol       Date:  2009-11-30       Impact factor: 2.408

8.  When to initiate disease-modifying drugs for relapsing remitting multiple sclerosis in adults?

Authors:  Mona Alkhawajah; Joel Oger
Journal:  Mult Scler Int       Date:  2011-05-17

9.  A Cognitive Occupation-Based Programme for People with Multiple Sclerosis: A Study to Test Feasibility and Clinical Outcomes.

Authors:  Sean Reilly; Sinéad M Hynes
Journal:  Occup Ther Int       Date:  2018-05-02       Impact factor: 1.448

10.  Association between smoking and cognitive impairment in multiple sclerosis.

Authors:  Muhammed Emin Ozcan; Bahri Ince; Ayhan Bingöl; Simge Ertürk; Meriç Adil Altınöz; Hasan Hüseyin Karadeli; Abdulkadir Koçer; Talip Asil
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.